Cannabis & CBD
Curaleaf revenue, results and funding
Curaleaf filed revenue of $1.3B for 2025.
Data updated Nov 22, 2026 · Back to the company report
$1.3BRevenue, 2025
−$231.1MNet income, 2025
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_CAPEX | LANG_CR_S_M_STAFF_COSTS | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT | LANG_CR_S_M_ACQUISITIONS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $1.3B | −$231.1M | $2.8B | $27.1B | $123.7M | $63.4M | $230.9M | $35.7M | $805k | $25.5M | – | $512.9M | $542k |
| 2024 | $1.3B | −$215.4M | $2.9B | $16.5M | $98.3M | $92.4M | $227.8M | $25.7M | $1.4M | $24.7M | – | $466.9M | $4.7M |
| 2023 | $1.3B | −$281.2M | $3.1B | $100M | $114.6M | $65.4M | $206.8M | $20M | – | $42.9M | – | $548.3M | $3.6M |
| 2022 | $1.3B | −$370.1M | $3.4B | $156M | $178.8M | $134.6M | $211.4M | $28M | – | $65M | $163.2M | $570.8M | $119.2M |
| 2021 | $1.2B | −$205.9M | $3.1B | $91.8M | $152.4M | $172M | $202.9M | $39.5M | – | $58.6M | $299.3M | $457.9M | $37.8M |
| 2020 | $626.6M | −$57.2M | $2.4B | $21.5M | $87.6M | $126.3M | – | $30.9M | – | $72.4M | $73.5M | $285M | $59.7M |
| 2019 | $221M | −$67.2M | $736.9M | $7.2M | $24.1M | $82.1M | – | $16.6M | – | −$27.7M | $42.3M | $88M | $80.6M |
| 2018 | – | – | – | – | – | – | – | – | – | – | $266.6M | – | – |
Sources: SEC
How to cite
Curaleaf, Financials. Alion, Nov 22, 2026. https://alion.io/company/curaleaf/financials
